Are there concerns about generic medicines in rheumatology?

Joint Bone Spine. 2014 Jan;81(1):1-3. doi: 10.1016/j.jbspin.2013.10.001. Epub 2013 Nov 20.

Authors

Bernard Bannwarth¹, Marie Kostine², Nicolas Poursac²

Affiliations

¹ Service de rhumatologie, Groupe hospitalier Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux, France; Laboratoire de thérapeutique, Université Bordeaux-Segalen, 33076 Bordeaux, France. Electronic address: bernard.bannwarth@u-bordeaux2.fr.
² Service de rhumatologie, Groupe hospitalier Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux, France.

PMID: 24268925
DOI: 10.1016/j.jbspin.2013.10.001

No abstract available

Keywords: Bioequivalence; Bisphosphonates; Generic drugs; International non-proprietary name (INN); Rheumatology.

Publication types

Editorial

MeSH terms

Drug Industry / legislation & jurisprudence
Drugs, Generic / pharmacology
Drugs, Generic / standards*
Europe
Humans
Legislation, Drug
Rheumatology*

Substances

Drugs, Generic